Complete Genomics News

Complete Genomics, Inc. : Upon the news that William Blair downgraded Complete Genomics shares from Outperform to Market Perform, prices fell drastically on the day.

Complete Genomics, Inc. : After Complete Genomics and a number of other small-cap genomic stocks surged over the past two days, Mizuho sees no news to justify the rallies.

The SPDR S&P Biotech ETF is up nearly 25 percent year-to-date. As large pharmaceuticals face major patent expirations in 2012 they have looked to biotech companies to provide new streams of revenue.

Your online resource for Micro-cap and penny stock news and information, AimHighProfits.com offers a high value free newsletter for the best penny stock picks around.

Reading International Inc shares advanced 45.47% to $6.59 at 12:00 pm. RDIB's trailing-twelve-month revenue is $254.21 million.

May 25, 2012 - www.InvestorIdeas.com, a global investor research specializing in sector research including China stocks, issues an investor alert for Complete Genomics, Inc.

MOUNTAIN VIEW, Calif. - May 9, 2012 - Complete Genomics Inc. announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in a Latino population.

Complete Genomics Inc. , the whole human genome sequencing company, today announced that it has signed four new distributor agreements with well-established Asia-Pacific life sciences companies - GeneWorks Pty Ltd.